By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...

COVID, flu and RSV levels have already hit their peaks. (Pollen levels and springtime allergies are a whole different story.) ...

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

The influenza virus, COVID-19 and the common cold are caused by different viruses. Consider getting vaccinated to keep ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) reported 15 more H5N1 avian flu ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

New Jersey joined 22 states suing the Trump administration to stop its plan to cut more than $11 billion in funding for ...

More than 190,000 people still sought medical help for acute respiratory infection (ARI), including 30,000 with ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.3/100K) and ...